Management of Acute Lower Limb Ischemia Without Surgical Revascularization - A Population-Based Study.
Stefan AcostaAndrea KulezicMoncef ZarroukAnders GottsäterPublished in: Vascular and endovascular surgery (2023)
Patients selected for initial conservative therapy of ALI with anticoagulation alone may have a good outcome, even when admitted with Rutherford class IIb ischemia. A low C-reactive protein level at admission seems to be a favorable marker when choosing conservative therapy. A prospective, preferably multicenter, study with a predefined protocol in these conservatively treated patients is warranted to better define the dose and length of anticoagulation therapy.
Keyphrases
- end stage renal disease
- newly diagnosed
- ejection fraction
- chronic kidney disease
- lower limb
- atrial fibrillation
- peritoneal dialysis
- venous thromboembolism
- randomized controlled trial
- liver failure
- intensive care unit
- percutaneous coronary intervention
- hepatitis b virus
- mesenchymal stem cells
- patient reported outcomes
- cell therapy
- drug induced
- bone marrow
- respiratory failure
- replacement therapy